Drug intelligence / Profile preview

Evolysse Sculpt

Development stage: Preclinical
Lead developer: Symatese
Administration: Intradermal, Subcutaneous

Overview

Evolysse Sculpt is an injectable hyaluronic acid (HA) dermal filler developed as part of the Evolysse collection, which utilizes proprietary Cold-X Technology. This technology preserves the natural structure of HA molecules by using near-freezing temperatures during manufacturing, resulting in a gel that integrates smoothly into facial tissue for natural-looking volume and contour enhancement. The product is designed to add structure, support, and symmetry to the face, addressing age-related or structural volume loss. As with other products in the Evolysse line, it aims for long-lasting results and high patient satisfaction with a favorable safety profile. The primary indication is aesthetic facial sculpting and volumization[1][6][8].

Brand names: Evolysse Sculpt

Beyond the preview

Go deeper on Evolysse Sculpt.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evolysse Sculpt.

Explore the full profile